357: The upheaval of CDC's vaccine panel, and drug pricing confusion
The Readout Loud
00:00
InsMed's Rise: A Game Changer in Biotech
This chapter explores InsMed's breakthrough inhaled treatment for pulmonary arterial hypertension, spotlighting its competitive edge and notable stock surge. It also examines the broader implications of pharmaceutical M&A trends and the potential outcomes for InsMed's independence amid acquisition rumors.
Transcript
Play full episode
